Compare ARK Genomic Revolution ETF (ARKG) vs Noble Corporation plc (NE) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Noble Corporation plc — how do they compare? ARK Genomic Revolution ETF trades at $40.95, while Noble Corporation plc trades at $40 (market cap $6.38B). The key difference: Noble Corporation plc pays a 5% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Noble Corporation plc nearer its low. Which is the better fit depends on your goals.
| ARKG | NE | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $54.37 |
52-Week Low | $23.09 | $25.70 |
Market Cap | — | $6.38B |
Enterprise Value | — | $7.63B |
Dividend Yield | — | 5% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Noble Corporation (NE) trades at $39.97, up 2.75% today, with a bearish technical signal and mixed quarterly earnings. The company maintains solid cash flow, with $228M net cash flow in 2025, and recently secured a three-well UKCS contract from BP. Valuation metrics show a P/E of 27.95 and EV/EBITDA of 7.2, while analyst consensus is divided with a $50 price target.
Outlook is cautious due to recent earnings misses and bearish technicals, but strong operational cash flow and new contracts offer stability. Risks include execution challenges and oil market volatility, while the dividend and low leverage provide shareholder support. Investors should weigh fundamental strength against near-term headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Noble Corporation plc
Noble Corporation plc is a leading offshore drilling contractor for the oil and gas industry. The company owns and operates a high-specification fleet of mobile offshore drilling units, including drillships and semi-submersibles, that are used for exploration and production activities in deepwater and harsh environments worldwide. Noble focuses on providing safe, efficient, and reliable drilling services to major and independent oil and gas companies globally.
Read more on NE →
